Related by context. All words. (Click for frequent words.) 74 TSRX 74 IMMU 73 BPAX 72 Nasdaq ACHN 72 IDIX 72 AUXL 72 CRTX 72 ATHX 72 NASDAQ ACHN 72 CRXX 72 DVAX 71 Achillion Pharmaceuticals Inc 71 ZIOP 71 RDEA 71 INCY 71 VRUS 71 LGND 71 OPXA 71 LXRX 70 OPTR 70 BNVI 70 SCLN 70 ONTY 70 IMGN 70 THRX 69 Seattle Genetics SGEN 69 MBRX 69 CYTR 69 RXII 69 AMEX RNN 69 ARQL 69 GTOP 69 THLD 69 ARYX 69 SLXP 69 non nucleoside inhibitor 69 AVNR 69 DRRX 69 AKRX 69 ALTH 69 DCTH 69 NASDAQ OPTR 69 DYAX 69 SOMX 69 REGN 69 Incyte Corp 68 NVLT 68 ENZN 68 CRXL 68 KERX 68 XNPT 68 ONCY 68 NASDAQ VRTX 68 Inhibitex INHX 68 Nasdaq PARD 68 CLDX 68 AFFY 68 Maribavir 68 AEGR 68 Idenix Pharmaceuticals 68 NGSX 68 SGEN 68 SGXP 68 AMRN 68 NBIX 67 AMEX ANX 67 NYMX 67 CRME 67 Initiates Clinical Trial 67 Immunomedics Inc 67 RPRX 67 Achillion Pharmaceuticals Inc. 67 Nasdaq ACAD 67 Cyclacel Pharmaceuticals 67 MDVN 67 BCRX 67 ABIO 67 NRGN 67 NNVC 67 PSDV 67 CPRX 67 INHX 67 oral prodrug 67 MOGN 67 VPHM 67 pan HDAC inhibitor 67 Vertex Pharmaceuticals Inc 67 OGXI 67 HEPH 67 Threshold Pharma 67 Optimer Pharma 67 SVNT 67 AEZS 67 Nasdaq OPTR 67 Presents Preclinical 67 Phase 2b Clinical Trial 67 Vion Pharmaceuticals 67 Rexahn Pharmaceuticals Inc. 67 NASDAQ ACAD 67 ONXX 67 Initiates Phase II 66 PVCT 66 OSUR 66 PHRM 66 Vicriviroc 66 Achieves Primary Endpoint 66 NASDAQ PARD 66 CYTX 66 Momenta Pharma MNTA 66 NASDAQ ONXX 66 Rexahn Pharmaceuticals 66 Telbivudine 66 Thiovir 66 Presents Preclinical Data 66 OTCBB NNVC 66 Cell Therapeutics Inc 66 Entremed 66 NASDAQ AVNR 66 TTHI 66 Biodel Inc 66 SGMO 66 NASDAQ REGN 66 Cypress Bioscience Inc 66 Therapeutic Competitors Companies 66 Ardea Biosciences 66 Keryx Biopharma 66 Guanilib 66 Nasdaq PGNX 66 NASDAQ IMMU 66 Anadys Pharma 66 Announces Poster Presentations 66 Sunesis Pharmaceuticals 66 Immunogen IMGN 66 NASDAQ OREX 66 Cepheid CPHD 66 Arqule 66 VNDA 66 Begins Dosing 66 AMEX INO 66 Plc Ads SHPGY 66 Oritavancin 66 MNTA 66 liposomal formulation 66 Completes Patient Enrollment 66 Idenix Pharma 66 KV.A 66 Immunotherapeutic 66 PCRX 66 NYSE Amex RNN 66 SUPG 65 SCRX 65 Drug Candidate 65 histone deacetylase HDAC inhibitor 65 Phase IIb Trial 65 Oncothyreon Inc 65 Meets Primary Endpoint 65 NASDAQ SNSS 65 Optimer Pharmaceuticals 65 DCGN 65 Nasdaq HALO 65 ALXA 65 NS#/#A protease 65 Cethromycin 65 NEXM 65 NASDAQ ISTA 65 Human Genome Sciences HGSI 65 Nasdaq RDEA 65 NASDAQ OPXA 65 Initiate Phase 65 NASDAQ SNTA 65 NovaBay Pharmaceuticals 65 Initiates Clinical 65 NASDAQ SGEN 65 VICL 65 Acadia Pharmaceuticals ACAD 65 VTUS 65 EPCT 65 Pafuramidine 65 Archexin 65 BIOD 65 NASDAQ AMLN 65 SHPGY 65 ZLCS 65 Cephalon NASDAQ CEPH 65 Aflibercept 65 NASDAQ OMER 65 NASDAQ CLDX 65 Salix Pharmaceuticals Ltd 65 Regeneron Pharma 65 Vertex Pharmaceuticals NASDAQ VRTX 65 Seattle Genetic SGEN 65 UGNE 65 NASDAQ ADLR 65 OXGN 65 ALNY 65 NASDAQ AEZS 65 Optimer Pharmaceuticals Inc 65 RNVS 65 NASDAQ INCY 65 EXAS 65 NVAX 65 VVUS 65 FOLOTYN ® 65 Peregrine Pharma 65 SSRX 65 Celldex Therapeutics NASDAQ CLDX 65 Immunogen 65 VRTX 65 PHARMACEUTICALS INC. 65 Vaccine Adjuvant 65 virus HCV protease inhibitor 65 Nymox Pharmaceutical 65 Onyx Pharmaceuticals Inc 65 BMRN 65 Idera Pharmaceuticals 64 Array Biopharma Inc 64 Nasdaq AVNR 64 Peregrine Pharmaceuticals 64 Pharmacokinetics PK 64 GERN 64 ISPH 64 PWRM.OB 64 HLCS 64 Phase 2a Clinical Trial 64 Sunesis Pharmaceuticals Inc 64 ZGEN 64 Threshold Pharmaceuticals 64 Anadys Pharmaceuticals 64 imatinib Gleevec ® 64 Therapeutic Competitors companiesandmarkets.com adEgemonye 64 MBRK 64 GNTA 64 GENR 64 Receives Orphan Drug Designation 64 MEDX 64 Investigational Compound 64 Omacetaxine 64 Nasdaq SLXP 64 TRBN 64 Tezampanel 64 Biosante Pharmaceuticals 64 radezolid 64 NASDAQ HGSI 64 HDAC Inhibitor 64 Personalized Immunotherapy 64 Presents Positive 64 Halozyme Therapeutics 64 NASDAQ SIGA 64 Phase IIb Clinical Trial 64 MYGN 64 Anidulafungin 64 Inc. NASDAQ DSCO 64 AVRX 64 SNTS 64 Nasdaq VNDA 64 Sunesis Pharma 64 Glufosfamide 64 Phase 2b Trial 64 Harbor BioSciences 64 NASDAQ VRUS 64 MT# MEDI 64 Reports Preclinical Data 64 OSIR 64 PANC 64 Eurand NV EURX 64 TRACON Pharmaceuticals 64 CRGN 64 QCOR 64 selective kinase inhibitor 64 OTCBB ADXS 64 HUMAN GENOME SCIENCES 64 Vaccine Candidate 64 NASDAQ ZIOP 64 OTCBB DORB 64 PROLOR Biotech Inc. 64 NASDAQ ENMD 64 NASDAQ VPHM 64 Nps Pharmaceuticals Incorporated 64 CYT# potent vascular disrupting 64 Allos Therapeutics Incorporated 64 NASDAQ IDIX 64 Inspire Pharmaceuticals Inc 64 PRTX 64 Immunomedics Inc. 64 midstage trials 64 Allos Therapeutics ALTH 64 LymphoStat B TM 64 Initiates Enrollment 64 SNSS 64 Nitazoxanide 64 GTXI 64 Targacept TRGT 64 MRNA 64 By JAMAAL ABDUL 64 Inc. Nasdaq IMGN 64 Inc. NASDAQ XNPT 64 Myriad Genetics Inc 64 GNLB 63 Cyclacel Pharmaceuticals Inc. 63 ATL/TV# 63 please visit http:/www.vandapharma.com 63 Acadia Pharmaceuticals 63 AMEX PLX 63 MNKD 63 AGEN 63 Pivotal Phase III 63 Vanda Pharmaceuticals Inc 63 NANX 63 Cubist Pharmaceuticals Inc 63 NASDAQ CYTR 63 Celgene NASDAQ CELG 63 Progenics Pharmaceuticals 63 MDCO 63 OTC BB PVCT 63 Annamycin 63 QGEN 63 Acorda Therapeutics Inc 63 AEterna Zentaris Inc. 63 NASDAQ IDRA 63 Keryx Biopharmaceuticals KERX 63 Æterna Zentaris Inc. 63 ENCY 63 TTNP 63 Nasdaq VRTX today 63 MKC# MT 63 Nasdaq IDIX 63 Phase 2a Trial 63 ABII 63 Receives Fast Track 63 Phase IIa Clinical Trial 63 Lexicon Pharmaceuticals 63 NovaBay Pharmaceuticals Inc. 63 Safinamide 63 Alexza Pharmaceuticals Inc 63 NASDAQ KERX 63 NASDAQ NVAX 63 BTRX 63 Nasdaq DEPO 63 Vical VICL 63 CLDA 63 SIGA Technologies Inc. 63 DepoMed 63 NOVARTIS 63 EXEL 63 Successfully Completes Phase 63 mitogen activated ERK kinase 63 AVII 63 Hsp# Inhibitor 63 Ridaforolimus 63 SGX Pharmaceuticals 63 midstage clinical 63 NASDAQ IMGN 63 Synergy Pharmaceuticals 63 essential thrombocythemia ET 63 Cyclacel Pharma 63 Cadence Pharmaceuticals Inc 63 AMEX RGN 63 PRXL 63 Incyte INCY 63 NEOP 63 Romidepsin 63 AAG geldanamycin analog 63 NASDAQ CORT 63 tigecycline 63 Ecallantide 63 SciClone Pharmaceuticals 63 Inc. NASDAQ OXGN 63 CADX 63 Nasdaq INCY 63 ISTA Pharmaceuticals 63 Affymax AFFY 63 RGDX 63 CCR5 antagonist 63 INSM 63 Inc. NASDAQ GNVC 63 Threshold Pharmaceuticals Inc. 63 Laquinimod 63 ONYX Pharmaceuticals 63 ABLYNX 63 NASDAQ RDEA 63 Nasdaq BCRX 63 NASDAQ ALTH 63 Submits NDA 63 Bristol Myers NYSE BMY 63 Xcytrin R 63 Alexion Pharmaceuticals Inc 63 NASDAQ VNDA 63 NASDAQ SVNT 63 HNAB 63 NASDAQ SLXP 63 Inc. NASDAQ NVAX 63 KSP inhibitor 63 FDA APPROVES 63 KOSN 63 PBTH 63 Panzem R 63 Inc. NASDAQ VVUS 63 Parathyroid Hormone 63 ACADIA Pharmaceuticals 63 lintuzumab SGN 63 Elagolix 63 torezolid 63 Files IND 63 SinuNase TM 63 Dalbavancin 63 NASDAQ PSTI 63 NASDAQ PCYC 63 Pharmos Corporation 63 2 methoxyestradiol 63 Inc. NASDAQ SGEN 63 POZN 63 Kinase Inhibitor 63 Exelixis EXEL 63 ASE SVA 63 NASDAQ ARIA 63 NASDAQ VVUS 63 XTL Biopharmaceuticals Ltd. 63 Ziopharm 62 Myelofibrosis 62 HCV polymerase 62 Aeolus Pharmaceuticals 62 NASDAQ CRME 62 Vertex Pharma 62 NASDAQ ANDS 62 PTIE 62 Lexicon Pharmaceuticals Inc 62 GNVC 62 RDYN 62 Synta Pharmaceuticals SNTA 62 Initiates Phase 62 ADXS 62 Initiates Phase 2b 62 Nasdaq IMGN 62 Gleevec imatinib mesylate 62 non nucleoside HCV 62 targeted radiotherapeutic 62 CEQ# 62 QLTI 62 Submits Response 62 Valopicitabine 62 NASDAQ BIOD 62 NVGN 62 dasatinib Sprycel ® 62 NASDAQ CYPB 62 Bezielle 62 novel defensin mimetic 62 PPHM 62 Carfilzomib 62 brivanib 62 investigational oral hepatitis C 62 intranasal formulation 62 GILEAD SCIENCES 62 AMEX PTN 62 RGEN 62 Mg Usa 62 Akorn Inc 62 Phase III Trials 62 Idenix Pharmaceuticals Inc. 62 Optimer Pharmaceuticals Inc. 62 Patient Enrollment 62 SPRYCEL ® 62 Xenoport Inc. 62 Difimicin 62 Therapeutic Competitors 62 NASDAQ MNKD 62 Theravance THRX 62 TRGT 62 Barrier Therapeutics Inc. 62 Onyx Pharmaceuticals NASDAQ ONXX 62 NASDAQ PGNX 62 NLTX 62 Nasdaq MBRX 62 Acorda Therapeutics NASDAQ ACOR 62 Nasdaq SNSS 62 HCV Protease Inhibitor 62 APCVZ 62 CYGX 62 BAL# [002] 62 NASDAQ CYCC 62 NASDAQ SCLN 62 polymerase inhibitor 62 LMNX 62 JAK inhibitor 62 nucleoside analog 62 Combination REOLYSIN R 62 Inc. NASDAQ AGIX 62 AMEX HEB 62 BSDM 62 Mylan Receives Approval 62 Therapeutic Vaccine 62 systemic fungal infections 62 Sunesis Pharmaceuticals Inc. 62 PYMX 62 ALXN 62 Keryx Biopharmaceuticals 62 Rigel Pharmaceuticals 62 Nasdaq CBST 62 Lenocta TM 62 Novelos Therapeutics 62 Factor VIIa 62 SHP.L 62 BMTI 62 TSPT 62 Nasdaq NRGN 62 Avanir Pharmaceuticals Inc 62 SQNM 62 Trubion Pharmaceuticals TRBN 62 NOVAVAX 62 NASDAQ OGXI 62 Nasdaq EPCT 62 Amgen Neulasta R 62 NASDAQ ACOR 62 NSTK 62 Panzem 62 Cypress Biosciences 62 NSPH 62 Pimavanserin 62 InterMune ITMN 62 Omeros Corporation 62 AMLN 62 Fast Track Status 62 Phase #b/#a clinical 62 Alnylam Pharma 62 thiazolides 62 GTHP 62 Receives Orphan Drug 62 Nasdaq IDRA 62 Interferon beta 1b 62 Earns Milestone Payment 62 Sapacitabine 62 Ardea Biosciences Inc. 62 Idenix Pharmaceuticals IDIX 62 Arena Pharmaceuticals ARNA 62 Pivotal Study 62 Nasdaq IMMU 62 OTCBB PYTO 62 Onyx Pharmaceuticals ONXX 62 Randomized Phase 62 NASDAQ ABIO 62 Migraine Drug 62 NASDAQ MNTA 62 Submits IND 62 NASDAQ RPRX 62 NASDAQ LGND 62 Nasdaq MITI 62 proteasome inhibitor 62 Idenix Pharmaceuticals Inc 61 NASDAQ NBIX 61 Pazopanib 61 Chemokine Therapeutics 61 ELGX 61 Brentuximab Vedotin SGN 61 Epratuzumab 61 nucleotide analog 61 Metabasis Therapeutics Inc. 61 HYTM 61 Auxilium Pharmaceuticals Inc 61 Provectus Pharmaceuticals 61 Nasdaq CYCC 61 SNGX 61 GSK '# 61 SAR# [002] 61 Transcept Pharmaceuticals 61 Entry Inhibitor 61 OXBT 61 Momenta Pharmaceuticals MNTA 61 PHARMACEUTICALS INC 61 NASDAQ MELA 61 Shire plc SHPGY 61 Ziopharm Oncology 61 receptor tyrosine kinase inhibitor 61 PNP inhibitor 61 NASDAQ INHX 61 Nasdaq CYTX 61 Vertex VRTX 61 Novavax NVAX 61 targeting CD# 61 Voreloxin 61 NASDAQ PANC 61 OncoGenex Pharmaceuticals Inc. 61 Enzon Pharmaceuticals Inc 61 OSI Pharmaceuticals OSIP 61 DSCO 61 NYSE Amex PTN 61 NASDAQ BCRX 61 OSI Pharma 61 ALIM 61 PFWD 61 Nasdaq SGEN 61 MEMY 61 VRNM 61 Severe Sepsis 61 Nektar Therapeutics NKTR 61 Salix Pharmaceuticals NASDAQ SLXP 61 NASDAQ HALO 61 MYRX 61 Onyx Pharmaceuticals 61 NASDAQ BMRN 61 Present Preclinical Data 61 Nasdaq CTIC 61 NASDAQ AVEO 61 PRT# 61 Inspire Pharma 61 NASDAQ LXRX 61 NASDAQ NYMX 61 Opexa Therapeutics Inc. 61 Aastrom Biosciences Inc 61 Exherin 61 Onyx Pharma 61 compound PMX # 61 ACUR 61 apricitabine ATC 61 NASDAQ GNBT 61 Aurora Kinase 61 MannKind MNKD 61 SNMX 61 Epidermal Growth Factor Receptor 61 CPHD 61 AVANIR Pharmaceuticals 61 OTCBB ILNS 61 diarrhea predominant irritable 61 Cypress Bioscience CYPB 61 Pivotal Phase 61 Hana Biosciences 61 ABGX 61 ViroPharma VPHM 61 NOVN 61 QTXB 61 cetuximab Erbitux R 61 ANIK 61 Inc. NASDAQ SUPG 61 acetonide FA 61 SinuNase ™ 61 NASDAQ ALXN 61 Corcept Therapeutics Incorporated 61 MLNM 61 NASDAQ INFI 61 immunotherapeutic vaccine 61 TKB# 61 Potent Antiviral Activity 61 Viropharma 61 OTCBB NPHC 61 MAGE A3 ASCI 61 Questcor Pharmaceuticals 61 Regeneron Pharmaceuticals Inc 61 VXGN 61 Nektar Therapeutics NASDAQ 61 mertansine 61 NASDAQ XOMA 61 HuMax CD4 61 Nymox Pharmaceutical Corporation 61 FLML 61 VCRT 61 TBC# 61 NASDAQ SOMX 61 Mpex 61 polycythemia vera essential thrombocythemia 61 Flamel Technologies 61 Milestone Payment 61 Nasdaq IPXL 61 Chronic Hepatitis C 61 Coley Pharmaceutical Group 61 AMYLIN PHARMACEUTICALS 61 PGNX 61 Phase III Clinical Trial 61 CYPB 61 investigational monoclonal antibody 61 S/GSK# 61 OTCBB PVCT 61 Osiris Therapeutics Inc 61 ara C 61 NASDAQ DEPO 61 PXSL 61 ASX PGL 61 Initiates Phase III 61 II Clinical Trial 61 Oral Fingolimod 61 ceftazidime 61 HGSI 61 Xyfid TM 61 Vascular Disrupting Agent 61 Dendreon DNDN 61 Friedreich Ataxia FRDA 61 pralatrexate injection folate analogue 61 GNBT 61 NASDAQ MIPI 61 Regeneron Pharmaceuticals NASDAQ REGN 61 Inc. NASDAQ MRNA 61 Ozarelix 61 investigational humanized monoclonal antibody 61 Nasdaq OMER 61 GILD GILD 61 PHARM 61 romidepsin novel 61 QuantRx Biomedical Corporation 61 Nasdaq RPRX 61 Dose Ranging Study 61 Regeneron Pharmaceuticals REGN 61 ITMN 61 Varespladib 61 BioMarin Pharmaceutical 61 CorMedix NYSE Amex 61 Myriad Genetics NASDAQ MYGN 61 Cetrorelix 61 hypereosinophilic syndrome 61 Inc. NASDAQ AVNR 61 ROSG 61 Complicated Skin 61 Inhalation Solution 61 NASDAQ VICL 61 NASDAQ ARRY 61 ARRY 61 VitiGam 61 Alnylam Nasdaq ALNY 61 itraconazole Sporanox 61 AVEO Pharmaceuticals Inc. 61 AVP #D# 61 HCV protease inhibitors 61 XenoPort NASDAQ XNPT 61 SEPR 61 Avanir Pharmaceuticals AVNR 61 Bosutinib 61 MOVIPREP R 61 Onconase 61 Corp. GERN 61 relapsed MM 61 Receives Approvable Letter 61 Æterna Zentaris 61 Neose Technologies 61 Lupus Drug 61 ARDM 61 BFRM 61 VTIV 61 Columbia Laboratories CBRX 61 Cannabinor 61 Myelodysplastic Syndrome MDS 61 NEPH 61 Clostridium difficile Infection 61 Adjuvant Treatment 61 Questcor Pharmaceuticals QCOR 61 Treatment Naïve 61 NASDAQ NPSP 61 ImmunoGen Inc. 61 Cytokinetics CYTK 61 Entecavir 60 Darinaparsin 60 Receive Milestone Payment 60 refractory gout 60 Altus Pharmaceuticals 60 oral candidiasis 60 Nanobody ® 60 Immunomedics IMMU 60 AVEO Pharmaceuticals 60 Medivation Inc 60 Inc. Nasdaq SGXP 60 OTCBB NVLT 60 NASDAQ ANPI 60 Aplidin 60 MEK inhibitor 60 myelodysplastic myeloproliferative diseases 60 CRMD pharmaceutical 60 Allovectin 7 60 FDA Accepts 60 Enzon Pharmaceuticals 60 orally administered inhibitor 60 P#X# antagonist 60 LibiGel ® 60 ganetespib 60 SUVN 60 Nasdaq TARG 60 ARCA Biopharma 60 PDGI 60 lumiliximab 60 Apricus Biosciences 60 Celgene Corp 60 topical gel containing 60 Dendreon Corp 60 JAK Inhibitor 60 Progenics Pharmaceuticals PGNX 60 psoriasis rheumatoid arthritis 60 NASDAQ AMAG 60 preclinical efficacy 60 Cutaneous T 60 TNGN 60 VIVUS VVUS 60 IND Application 60 First Patient Dosed 60 DORB 60 humanized monoclonal 60 DermaVir Patch 60 IND Filing 60 Inc. NASDAQ ZLCS 60 dasatinib Sprycel 60 TransVax TM 60 Commences Phase 60 OTCBB AFLB 60 Compugen NASDAQ CGEN 60 Pluristem Therapeutics 60 Perifosine 60 Ohr Pharmaceutical Inc. 60 phase IIb clinical 60 Completes Enrollment 60 IPXL 60 TapImmune Inc. 60 Spectrum Pharmaceuticals SPPI 60 Neurocrine Biosciences NBIX 60 EYET 60 Inc. Nasdaq VVUS 60 Inc SPPI 60 Inc Therapeutic Competitors 60 LymphoStat B belimumab 60 FDA Approvals 60 protein kinase inhibitor 60 XOMA XOMA 60 anidulafungin 60 immune globulin intravenous 60 lexidronam injection 60 PDE4 inhibitor 60 Evoltra ® 60 chemotherapy induced neutropenia 60 Vaccine Recombinant 60 chronic eosinophilic leukemia 60 lucinactant 60 VentiRx Pharmaceuticals 60 Nasdaq LXRX 60 MT#/MEDI-# 60 molecular imaging radiopharmaceutical 60 Infected Patients 60 REGENERX BIOPHARMACEUTICALS INC. 60 Nasdaq GNBT 60 PANVAC VF 60 alfa 2a 60 Aveo Pharmaceuticals 60 SRDX 60 Irinotecan 60 Phase Ib clinical trials 60 Cell Genesys CEGE 60 Ligand Pharmaceuticals NASDAQ LGND 60 Muraglitazar 60 Savient Pharmaceuticals SVNT 60 Nasdaq RXII 60 plc AMRN 60 OTCBB EMIS 60 Milestone Payments 60 NASDAQ BJGP 60 NASDAQ DDSS 60 Phase Ib clinical 60 Patient Enrolment 60 alvespimycin 60 Systemic Delivery 60 Genelabs Technologies Inc. 60 reversible inhibitor 60 Corp. ADLR 60 AMAG Pharmaceuticals 60 Granted Orphan Drug 60 Nasdaq ALTH 60 AMEX CVM 60 NXL# 60 CBLI 60 Ariad Pharmaceuticals 60 Traficet EN 60 XL# anticancer compounds 60 Pharmasset VRUS 60 Lorus Therapeutics 60 ELTP 60 Panzem NCD 60 documented candidiasis 60 NASDAQ ABII 60 Xanafide 60 Vanda Pharmaceuticals Inc. 60 phase III isavuconazole 60 Commence Phase 60 NASDAQ AKRX 60 baminercept 60 Daclizumab 60 Pegloticase 60 NASDAQ SVA 60 thalidomide Thalomid 60 BioCryst Pharma 60 beta 1a 60 Avanir Pharmaceuticals 60 Nasdaq THLD 60 elotuzumab 60 Fibrocell Science Inc. 60 SHARES DROP 60 Integrase Inhibitor 60 Corp. AMEX CVM 60 FluCide 60 Ramoplanin 60 Nasdaq OSIP 60 white petrolatum Ointment 60 Completes Dosing 60 darinaparsin ZIO 60 Alexion Pharmaceuticals ALXN 60 NASDAQ INGN 60 JAK2 Inhibitor 60 NASDAQ DRRX 60 Silodosin 60 Cancidas 60 MCSP respectively 60 Synta Pharmaceuticals 60 NYSE NVO 60 Arpida 60 Tesmilifene 60 Palatin Technologies Inc. 60 Romiplostim 60 Eurand NV 60 novel histone deacetylase 60 daptomycin 60 HIV integrase inhibitor 60 Million Milestone Payment 60 evaluating tivozanib 60 Trius Therapeutics 60 Medarex MEDX 60 Inc. Nasdaq AVRX 60 adalimumab Humira 60 Rheumatoid Arthritis Drug 60 PHASE III 60 Panacos Pharmaceuticals Inc. 60 ADLR 60 Metabasis Therapeutics 60 Nasdaq IDIX biopharmaceutical 60 TELINTRA 60 Chronic Hepatitis B 60 StaphVAX R 60 telaprevir VX 60 ZymoGenetics ZGEN 60 Nasdaq NPSP 60 NASDAQ AUXL 60 Martek Biosciences MATK 60 Nasdaq ADLR 60 Ambrisentan 60 Initiates Clinical Trials 60 Generex Biotechnology Corp. 60 NASDAQ DCTH 60 MZEI 60 initiated Phase Ib 60 invasive candidiasis 60 Nasdaq MITI biopharmaceutical 60 Previously Treated 60 NASDAQ DSCO 60 Amex ANX 60 programs visit http:/www.bionovo.com 60 Nasdaq VRTX 60 Inovio Biomedical Corporation 60 Penwest Pharma 60 Interferon Beta 60 HQK 60 Progenics Pharmaceuticals Inc 60 Par Pharmaceutical PRX 60 induced macular edema 60 Indevus Pharma 60 Initiate Clinical Trial 60 NASDAQ CYTX 60 Civacir 60 Ziopharm Oncology Inc. 60 Investigational Treatment 60 TRO# 60 Vertex Pharmaceuticals VRTX 60 Nasdaq KERX 60 NASDAQ BDSI 60 Insmed Incorporated NASDAQ INSM 60 Ariad Pharmaceuticals ARIA 60 Drug Fails 59 rilonacept 59 NYSE Amex YMI 59 NASDAQ FLML 59 MyVax R 59 oral proteasome inhibitor 59 elvucitabine 59 NASDAQ APPY 59 Troxatyl TM 59 Peginterferon alfa 2b 59 PRN FDA Approves 59 Presents Positive Preclinical 59 NASDAQ ALXA 59 Actelion Ltd 59 PBIO 59 Inovio Pharmaceuticals 59 Antiviral Therapy 59 Albuferon TM 59 VQD 59 GENZ 59 Phase 1b Clinical Trial 59 tramiprosate Alzhemed TM 59 Nasdaq CADX 59 Auxilium Pharmaceuticals 59 Etravirine 59 CLINICAL DATA 59 developing Zerenex ferric 59 Genentech Rituxan 59 Inc. Nasdaq INFI 59 tiapamil 59 Vicuron Pharmaceuticals 59 Salix Pharmaceuticals SLXP 59 oral Hsp# inhibitor 59 R roscovitine 59 Alnylam ALNY 59 Isis Pharmaceuticals ISIS